Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Employees - 23,
CEO - Timothy Pickett,
Sector - Healthcare,
Country - US,
Market Cap -
Altman ZScore(max is 10): 49.51, Piotroski Score(max is 10): 2, Working Capital: $5881838, Total Assets: $9890282, Retained Earnings: $-11227499, EBIT: -5472958, Total Liabilities: $923394, Revenue: $2239936
- Current Price $ - Analyst Target Price $Ticker | NAKA |
Index | |
Curent Price | |
Change | |
Market Cap | |
Average Volume | |
Income | |
Sales | |
Book Value/Share | |
Cash/Share | |
Dividend Est | |
Dividend TTM | |
Dividend Ex-Date | |
Employees | |
Moving Avg 20days | |
Moving Avg 50days | |
Moving Avg 200days | |
Shares Outstanding | |
Earnings Date | |
Inst. Ownership |
Price/Earnings | |
Forwad P/E | |
PE Growth | |
Price/Sales | |
Price/Book | |
Price/Cash | |
Price/FCF | |
Quick Ratio | |
Current Ratio | |
Debt/Equity | |
Return on Assets | |
Return on Equity | |
Return on Investment | |
Gross Margin | |
Ops Margin | |
Profit Margin | |
RSI | |
BETA(β) | |
From 52week Low | |
From 52week High |
EPS | |
EPS next Year | |
EPS next Qtr | |
EPS this Year | |
EPS next 5 Year | |
EPS past 5 Year | |
Sales past 5 Year | |
EPS Y/Y | |
Sales Y/Y | |
EPS Q/Q | |
Sales Q/Q | |
Sales Surprise | |
EPS Surprise | |
ATR(14) | |
Perf Week | |
Perf Month | |
Perf Quarter | |
Perf Year | |
Perf YTD | |
Target Price |
AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer